Medpace Holdings Inc (01P F) stock market data APIs
€275.4409
4.93(1.8%)
as of July 11, 2025
Try our APIs with
free plan!
Medpace Holdings Inc Financial Data Overview
Price chart is built with
Anychart
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Prev. Close
275.4409
Open
280.3719
High
280.3719
Low
271.3697
52 wk Range
227.7-418.7
Market Cap
7 930 M
P/E Ratio
24.6339
Shares Outstanding
28 742 K
Revenue
2 157 M
EPS
1.06
Beta
1.475
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Medpace Holdings Inc data using free add-ons & libraries
Get Medpace Holdings Inc Fundamental Data
Medpace Holdings Inc Fundamental data includes:
- Net Revenue: 2 157 M
- EBITDA: 486 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-07-26
- EPS/Forecast: 0.99
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Medpace Holdings Inc News
New
Medpace Holdings, Inc.'s (NASDAQ:MEDP) Stock Is Going Strong: Is the Market Following Fundamentals?
Medpace Holdings (NASDAQ:MEDP) has had a great run on the share market with its stock up by a significant 5.4% over the last month. Given that the market rewards strong financials in the long-term, we...
Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)
Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. Companies specializing in drug ...
Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025
CINCINNATI, June 23, 2025--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its second quarter 2025 financial results after the market close on Mo...
2 Reasons to Watch MEDP and 1 to Stay Cautious
Over the last six months, Medpace’s shares have sunk to $293, producing a disappointing 11.5% loss - a stark contrast to the S&P 500’s 1.7% gain. This may have investors wondering how to approach ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
